Caren Deardorf - Chief Commercial Officer at Dianthus Therapeutics, Inc. /DE/

Issuer-level insider activity

Role
Chief Commercial Officer
Issuer ticker
DNTH on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Caren Deardorf since 16 Aug 2025

Reported holdings for Caren Deardorf in Dianthus Therapeutics, Inc. /DE/

Form 4 holding Chief Commercial Officer

Magenta Therapeutics, Inc.

Security class
Common Stock
Shares / value
19,762
Estimated value
$237,144
Report date
30 Nov 2022
Price
$12.00
Ownership
Direct

Transaction history for Caren Deardorf in Dianthus Therapeutics, Inc. /DE/

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .